Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy.


Journal

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
ISSN: 1542-474X
Titre abrégé: Ann Noninvasive Electrocardiol
Pays: United States
ID NLM: 9607443

Informations de publication

Date de publication:
09 2019
Historique:
received: 14 09 2018
revised: 11 06 2018
accepted: 26 11 2018
pubmed: 10 2 2019
medline: 5 8 2020
entrez: 10 2 2019
Statut: ppublish

Résumé

Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHCM) is an uncommon type of HCM. LV apical aneurysms are present in more than 20% MVOHCM cases and has been identified as an independent predictor of potentially lethal arrhythmic events, including non-sustained or sustained ventricular tachycardia (VT), and ventricular fibrillation (VF), as well as SCD. Although the pathogenesis of LVA remains unknown, but it has been suggested that apical aneurysm may be secondary to the increased after-load and high apical pressure arising from significant pressure gradient of the midventricular obstruction. The scarred rim of the aneurysm and the adjacent areas of LV myocardial fibrosis and consequent apical oxygen-demand mismatch may be responsible for the formation of apical aneurysm. Recent electrophysiologic studies have demonstrated that the aneurysmal rim forms the primary culprit arrhythmogenic substrate for generation of monomorphic ventricular tachycardia leading to SCD, but the clinical significance of the size of aneurysm in relation to SCD remains unsettled. We summarized the clinical features of the patients with MVOHCM and apical aneurysms. Appropriate therapeutic interventions include ICD implantation, and early surgical intervention for gradient relief may be undertaken to relief the MVO.

Identifiants

pubmed: 30737990
doi: 10.1111/anec.12638
pmc: PMC6931486
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12638

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Ann Noninvasive Electrocardiol. 2016 Nov;21(6):618-621
pubmed: 27422472
Can J Cardiol. 2014 Apr;30(4):441-7
pubmed: 24468417
Ann Noninvasive Electrocardiol. 2016 Jan;21(1):98-101
pubmed: 26105174
J Am Coll Cardiol. 2017 Feb 21;69(7):761-773
pubmed: 28209216
Pacing Clin Electrophysiol. 2018 Jul;41(7):854-865
pubmed: 29786883
J Am Coll Cardiol. 2014 Jul 8;64(1):83-99
pubmed: 24998133
Gen Thorac Cardiovasc Surg. 2011 May;59(5):354-8
pubmed: 21547632
Eur J Cardiothorac Surg. 2015 Aug;48(2):334-5
pubmed: 25274496
Sci Rep. 2017 Sep 20;7(1):11957
pubmed: 28931939
Circulation. 2008 Oct 7;118(15):1541-9
pubmed: 18809796
Ann Noninvasive Electrocardiol. 2017 May;22(3):
pubmed: 28012232
Circ J. 2013;77(9):2366-74
pubmed: 23728066
Int J Cardiol. 2011 Aug 18;151(1):e8-9
pubmed: 20236715
J Cardiovasc Electrophysiol. 2010 Sep;21(9):991-9
pubmed: 20487113
Ann Thorac Surg. 2011 Apr;91(4):1263-5
pubmed: 21440157
Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12638
pubmed: 30737990
J Am Coll Cardiol. 2011 Jun 7;57(23):2346-55
pubmed: 21636036
J Cardiovasc Ultrasound. 2014 Sep;22(3):158-9
pubmed: 25309696
Tex Heart Inst J. 2007;34(4):475-8
pubmed: 18172535
J Cardiovasc Med (Hagerstown). 2015 Nov;16(11):751-60
pubmed: 25022933
Heart. 2003 Feb;89(2):178
pubmed: 12527672
Chin Med J (Engl). 2011 Jun;124(11):1754-7
pubmed: 21740793
Int J Cardiovasc Imaging. 2006 Feb;22(1):13-8
pubmed: 16372141
Cardiovasc Ultrasound. 2009 Jun 16;7:26
pubmed: 19527529
J Am Coll Cardiol. 2003 Nov 5;42(9):1687-713
pubmed: 14607462

Auteurs

Li Cui (L)

Department of Cardiology, Tianjin People's Hospital, Tianjin, 300120, People's Republic of China.

Gary Tse (G)

Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.

Zhiqiang Zhao (Z)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.

George Bazoukis (G)

Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.

Konstantinos P Letsas (KP)

Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.

Panagiotis Korantzopoulos (P)

First Department of Cardiology, University of Ioannina Medical School, Ioannina, Greece.

Leonardo Roever (L)

Department of Clinical Research, Federal University of Uberlândia, Brazil.

Guangping Li (G)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.

Tong Liu (T)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH